186 related articles for article (PubMed ID: 37256547)
1. Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review.
Goel H; Carey M; Elshaikh A; Krinock M; Goyal D; Nadar SK
J Cardiovasc Pharmacol; 2023 Aug; 82(2):69-85. PubMed ID: 37256547
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Hanai Y; Mita M; Hishinuma S; Shoji M
Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.
Kones R
Vasc Health Risk Manag; 2010 Sep; 6():749-74. PubMed ID: 20859545
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy in angina pectoris].
Follath F
Praxis (Bern 1994); 1995 Oct; 84(42):1186-9. PubMed ID: 7481332
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator Therapy: Nitrates and Nicorandil.
Tarkin JM; Kaski JC
Cardiovasc Drugs Ther; 2016 Aug; 30(4):367-378. PubMed ID: 27311574
[TBL] [Abstract][Full Text] [Related]
6. Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
Park T; Park JY; Rha SW; Seo HS; Choi BG; Choi SY; Byun JK; Park SH; Park EJ; Choi JY; Park SH; Lee JJ; Lee S; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Oh DJ
Yonsei Med J; 2017 Jan; 58(1):90-98. PubMed ID: 27873500
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Angina: Where Are We?
Balla C; Pavasini R; Ferrari R
Cardiology; 2018; 140(1):52-67. PubMed ID: 29874661
[TBL] [Abstract][Full Text] [Related]
8. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
Markham A; Plosker GL; Goa KL
Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
[TBL] [Abstract][Full Text] [Related]
9. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries.
Ninomiya Y; Hamasaki S; Saihara K; Ishida S; Kataoka T; Ogawa M; Orihara K; Oketani N; Fukudome T; Okui H; Ichiki T; Shinsato T; Kubozono T; Mizoguchi E; Ichiki H; Tei C
Heart Vessels; 2008 Mar; 23(2):83-90. PubMed ID: 18389331
[TBL] [Abstract][Full Text] [Related]
12. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.
Turgeon RD; Pearson GJ; Graham MM
Am J Cardiol; 2018 Apr; 121(7):888-895. PubMed ID: 29394999
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Krumenacker M; Roland E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
[TBL] [Abstract][Full Text] [Related]
15. [Optimal Diagnostics and Therapy for Microvascular Angina Pectoris].
Ong P; Sechtem U
Dtsch Med Wochenschr; 2017 Oct; 142(21):1586-1593. PubMed ID: 29046002
[TBL] [Abstract][Full Text] [Related]
16. Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.
Kusama Y; Kodani E; Nakagomi A; Otsuka T; Atarashi H; Kishida H; Mizuno K
J Nippon Med Sch; 2011; 78(1):4-12. PubMed ID: 21389642
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil: animal pharmacology.
Sakai K
Am J Cardiol; 1989 Jun; 63(21):2J-10J. PubMed ID: 2525321
[TBL] [Abstract][Full Text] [Related]
18. Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000.
Darius H
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S15-20; discussion S29-31. PubMed ID: 10499556
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of Vasospastic Angina.
Harris JR; Hale GM; Dasari TW; Schwier NC
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):439-51. PubMed ID: 27081186
[TBL] [Abstract][Full Text] [Related]
20. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
Cohn PF
Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
